• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑海绵状血管畸形出血:定义与报告标准。血管瘤联盟科学咨询委员会。

Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board.

作者信息

Al-Shahi Salman Rustam, Berg Michel J, Morrison Leslie, Awad Issam A

机构信息

Division of Clinical Neurosciences, Western General Hospital, Edinburgh, UK.

出版信息

Stroke. 2008 Dec;39(12):3222-30. doi: 10.1161/STROKEAHA.108.515544. Epub 2008 Oct 30.

DOI:10.1161/STROKEAHA.108.515544
PMID:18974380
Abstract

BACKGROUND AND PURPOSE

Cavernous malformations of the brain (CMs) cause intracranial hemorrhage, but its reported frequency varies, partly attributable to study design. To improve the validity of future research, we aimed to develop a robust definition of CM hemorrhage.

METHODS

We systematically reviewed the published literature (Ovid Medline and Embase to June 1, 2007) for definitions of CM hemorrhage used in studies of the untreated clinical course of >or=20 participants with CM(s), to inform the development of a consensus statement on the clinical and imaging features of CM hemorrhage at a scientific workshop of the Angioma Alliance.

RESULTS

A systematic review of 1426 publications about CMs in humans, revealed 15 studies meeting our inclusion criteria. Although 14 (93%) studies provided a definition of CM hemorrhage, data were less complete on the confirmatory type(s) of imaging (87%), whether CM hemorrhage should be clinically symptomatic (73%), and whether hemorrhage had to extend outside the CM or not (47%). We define a CM hemorrhage as requiring acute or subacute onset symptoms (any of: headache, epileptic seizure, impaired consciousness, or new/worsened focal neurological deficit referable to the anatomic location of the CM) accompanied by radiological, pathological, surgical, or rarely only cerebrospinal fluid evidence of recent extra- or intralesional hemorrhage. The definition includes neither an increase in CM diameter without other evidence of recent hemorrhage, nor the existence of a hemosiderin halo.

CONCLUSIONS

A consistent approach to clinical and brain imaging classification of CM hemorrhage will improve the external validity of future CM research.

摘要

背景与目的

脑海绵状血管畸形(CMs)可导致颅内出血,但其报道的发生率有所不同,部分原因在于研究设计。为提高未来研究的有效性,我们旨在制定一个关于CM出血的可靠定义。

方法

我们系统检索了已发表的文献(截至2007年6月1日的Ovid Medline和Embase),以查找在对≥20例患有CM的参与者进行未经治疗的临床病程研究中所使用的CM出血定义,为在血管瘤联盟科学研讨会上就CM出血的临床和影像学特征制定共识声明提供参考。

结果

对1426篇关于人类CMs的出版物进行系统评价后,发现有15项研究符合我们的纳入标准。尽管14项(93%)研究给出了CM出血的定义,但在影像学的确诊类型(87%)、CM出血是否应具有临床症状(73%)以及出血是否必须扩展至CM之外(47%)等方面的数据并不完整。我们将CM出血定义为需要有急性或亚急性起病的症状(以下任何一种:头痛、癫痫发作、意识障碍或与CM解剖位置相关的新出现或加重的局灶性神经功能缺损),同时伴有近期病灶外或病灶内出血的放射学、病理学、手术学证据,或很少情况下仅为脑脊液证据。该定义既不包括无近期出血其他证据的CM直径增加,也不包括含铁血黄素环的存在。

结论

对CM出血进行临床和脑影像学分类的一致方法将提高未来CM研究的外部有效性。

相似文献

1
Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board.脑海绵状血管畸形出血:定义与报告标准。血管瘤联盟科学咨询委员会。
Stroke. 2008 Dec;39(12):3222-30. doi: 10.1161/STROKEAHA.108.515544. Epub 2008 Oct 30.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
4
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
5
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.抗癫痫药物单药治疗癫痫:一项个体参与者数据的网络荟萃分析。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD011412. doi: 10.1002/14651858.CD011412.pub4.
6
Treatments for seizures in catamenial (menstrual-related) epilepsy.月经性(与月经相关)癫痫发作的治疗。
Cochrane Database Syst Rev. 2021 Sep 16;9(9):CD013225. doi: 10.1002/14651858.CD013225.pub3.
7
Pregabalin add-on for drug-resistant focal epilepsy.普瑞巴林添加治疗耐药性局灶性癫痫。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD005612. doi: 10.1002/14651858.CD005612.pub5.
8
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.拉莫三嗪与卡马西平单药治疗癫痫的疗效比较:个体参与者数据回顾
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD001031. doi: 10.1002/14651858.CD001031.pub4.
9
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
10
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.卡马西平与苯妥英钠单药治疗癫痫:个体参与者数据回顾
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD001911. doi: 10.1002/14651858.CD001911.pub3.

引用本文的文献

1
Medical management and intervention (using neurosurgical resection or stereotactic radiosurgery) versus medical management alone for symptomatic brain cavernoma: the CARE pilot RCT.有症状的脑海绵状血管瘤采用药物治疗与干预(使用神经外科切除术或立体定向放射外科手术)对比单纯药物治疗:CARE试点随机对照试验
Health Technol Assess. 2025 Aug;29(38):1-24. doi: 10.3310/GJRS5321.
2
Lifetime Risk of First Symptomatic ICH or Seizure in Familial Cerebral Cavernous Malformations: A Multicenter Patient Data Analysis.家族性脑海绵状血管畸形首次出现症状性脑出血或癫痫发作的终生风险:一项多中心患者数据分析。
Neurology. 2025 Aug 12;105(3):e213798. doi: 10.1212/WNL.0000000000213798. Epub 2025 Jul 10.
3
Epidemiology and Aetiology of Cerebral Cavernous Malformations.
脑海绵状血管畸形的流行病学与病因学
Acta Neurochir Suppl. 2025;136:143-149. doi: 10.1007/978-3-031-89844-0_18.
4
Identifying features of prior hemorrhage in cerebral cavernous malformations on quantitative susceptibility maps: a machine learning pilot study.基于定量磁化率图识别脑海绵状血管畸形中既往出血的特征:一项机器学习初步研究
J Neurosurg. 2025 Jul 4:1-8. doi: 10.3171/2025.3.JNS243051.
5
High-throughput differentiation of human blood vessel organoids reveals overlapping and distinct functions of the cerebral cavernous malformation proteins.人血管类器官的高通量分化揭示了脑海绵状血管畸形蛋白的重叠和独特功能。
Angiogenesis. 2025 Jun 6;28(3):32. doi: 10.1007/s10456-025-09985-5.
6
Antithrombotic therapy and cavernoma bleeding: does vascular border zone localization matter?抗栓治疗与海绵状血管瘤出血:血管边界区定位重要吗?
Front Surg. 2025 Apr 30;12:1577820. doi: 10.3389/fsurg.2025.1577820. eCollection 2025.
7
Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial.阿托伐他汀用于脑海绵状畸形再出血的安全性和有效性(AT CASH EPOC):一项1/2a期随机安慰剂对照试验。
Lancet Neurol. 2025 Apr;24(4):295-304. doi: 10.1016/S1474-4422(25)00036-5.
8
Clinical, genomic, and histopathologic diversity in cerebral cavernous malformations.脑海绵状血管畸形的临床、基因组和组织病理学多样性。
Acta Neuropathol Commun. 2025 Feb 5;13(1):23. doi: 10.1186/s40478-025-01940-1.
9
Improving methodology of radiosurgery for posterior fossa cavernomas: higher volume, lower dose.改善后颅窝海绵状血管瘤的放射外科治疗方法:更大体积,更低剂量。
Acta Neurochir (Wien). 2025 Feb 1;167(1):29. doi: 10.1007/s00701-024-06409-z.
10
Circulating molecules reflect imaging biomarkers of hemorrhage in cerebral cavernous malformations.循环分子反映脑海绵状血管畸形出血的成像生物标志物。
J Cereb Blood Flow Metab. 2025 Jun;45(6):1153-1165. doi: 10.1177/0271678X251314366. Epub 2025 Jan 20.